Global Cord Blood Corpora... (CO)
NYSE: CO
· Real-Time Price · USD
2.99
0.77 (34.68%)
At close: Jun 09, 2023, 3:43 PM
Global Cord Blood Balance Sheet Statement
Financials in CNY. Fiscal
year is
April - March.
Fiscal Year | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jul 5, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Cash & Equivalents | 1.05B | 6.66B | 6.51B | 6.39B | 6.24B | 6.08B | 5.87B | 5.73B | 5.57B |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | 282.3M | 296.86M | 298.1M | 311M | 307.04M | 311.08M | 309.8M | 308.56M |
Other Long-Term Assets | 163.94M | 696.19M | 691.63M | 678.17M | 667.88M | 653.41M | 635.8M | 624.61M | 614.94M |
Receivables | 25.45M | 161.3M | 154.07M | 144.67M | 135.41M | 135.07M | 128.96M | 121.72M | 111.64M |
Inventory | 7.24M | 45.88M | 47.39M | 33.82M | 36.96M | 44.26M | 57.09M | 56.11M | 52.46M |
Other Current Assets | 10.54M | 11.94M | 75.72M | 79.34M | 66.91M | 43.01M | 57.23M | 67.6M | 79.53M |
Total Current Assets | 1.09B | 6.94B | 6.78B | 6.65B | 6.48B | 6.3B | 6.11B | 5.97B | 5.81B |
Property-Plant & Equipment | 75.2M | 476.69M | 483.66M | 488.4M | 493.31M | 503.69M | 514.5M | 520.24M | 520.65M |
Goodwill & Intangibles | 13.18M | 83.58M | 84.74M | 85.89M | 87.05M | 88.2M | 89.36M | 90.51M | 91.67M |
Total Long-Term Assets | 252.32M | 1.6B | 1.62B | 1.61B | 1.62B | 1.61B | 1.6B | 1.6B | 1.59B |
Total Assets | 1.35B | 8.53B | 8.4B | 8.26B | 8.09B | 7.91B | 7.72B | 7.57B | 7.4B |
Account Payables | 1.31M | 8.33M | 11.67M | 13.44M | 13.88M | 9.48M | 9.74M | 12.32M | 14.31M |
Deferred Revenue | 72.29M | 458.26M | 451.97M | 451.02M | 453.66M | 449.36M | 423.35M | 420.52M | 404.4M |
Short-Term Debt | n/a | 147K | 1.7M | 1.68M | 1.66M | 1.64M | 3.12M | 1.6M | 1.74M |
Other Current Liabilities | 28.39M | 179.82M | 171.15M | 184.64M | 175.36M | 166M | 155.27M | 160.77M | 159.53M |
Total Current Liabilities | 101.99M | 646.56M | 636.49M | 650.78M | 644.55M | 626.47M | 591.48M | 595.2M | 579.99M |
Long-Term Debt | 23K | n/a | n/a | 50K | 99K | 147K | 195K | 1.72M | 1.75M |
Other Long-Term Liabilities | 79.67M | 505.17M | 499.9M | 495.83M | 489.34M | 482.22M | 473.99M | 467.24M | 459.89M |
Total Long-Term Liabilities | 473.71M | 3B | 2.97B | 2.95B | 2.92B | 2.89B | 2.86B | 2.83B | 2.79B |
Total Liabilities | 575.7M | 3.65B | 3.61B | 3.6B | 3.57B | 3.52B | 3.45B | 3.42B | 3.37B |
Total Debt | 23K | 147K | 1.7M | 1.73M | 1.75M | 1.78M | 3.31M | 3.32M | 3.49M |
Common Stock | n/a | 83K | 83K | 83K | 83K | 83K | 83K | 83K | 83K |
Retained Earnings | 455.45M | 2.89B | 2.78B | 2.65B | 2.52B | 2.39B | 2.26B | 2.14B | 2.01B |
Comprehensive Income | n/a | -106.79M | -106.72M | -105.35M | -105.13M | -103.18M | -103.59M | -99.3M | -95.1M |
Shareholders Equity | 769.69M | 4.88B | 4.77B | 4.64B | 4.52B | 4.38B | 4.25B | 4.14B | 4.01B |
Total Investments | n/a | 282.3M | 296.86M | 298.1M | 311M | 307.04M | 311.08M | 309.8M | 308.56M |